Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Diabetes Care|October 4, 2013
Association of hypoglycemic treatment regimens with cardiovascular outcomes in overweight and obese subjects with type 2 diabetes: a substudy of the SCOUT trialAdam Ali Ghotbi, Lars Køber, Nick Finer, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 9, 2013
Feasibility and indicative results from a 12-month low-energy liquid diet treatment and maintenance programme for severe obesityMichael Lean, Naomi Brosnahan, Philip McLoone, et al.
Plos One|March 28, 2013
Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individualsHelle Skak-Nielsen, Christian Torp-Pedersen, Nick Finer, et al.
Nutrition & Metabolism|October 16, 2009
Differential changes in serum uric acid concentrations in sibutramine promoted weight loss in diabetes: results from four weeks of the lead-in period of the SCOUT trialCharlotte Andersson, Peter Weeke, Bente Brendorp, et al.
BMC Endocrine Disorders|February 27, 2010
The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in periodPeter Weeke, Charlotte Andersson, Emil L Fosbøl, et al.
The American Journal of Clinical Nutrition|July 30, 2003
Leisure-time activity is an important determinant of long-term weight maintenance after weight loss in the Sibutramine Trial on Obesity Reduction and Maintenance (STORM trial)Marleen A van Baak, Edgar van Mil, Arne V Astrup, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 22, 2016
Relation between weight loss and causes of death in patients with cardiovascular disease: finding from the SCOUT trialAldo P Maggioni, Ian D Caterson, Renato Urso, et al.
The New England Journal of Medicine|September 8, 2010
Effect of sibutramine on cardiovascular outcomes in overweight and obese subjectsW Philip T James, Ian D Caterson, Walmir Coutinho, et al.
Diabetes|April 29, 2006
Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoAMiguel López, Christopher J Lelliott, Sulay Tovar, et al.
Metabolism: Clinical and Experimental|May 21, 2009
Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trialCharlotte Andersson, Peter Weeke, Emil Loldrup Fosbøl, et al.
Pageof 5